Enhancement of Mast Cell Degranulation Mediated by Purinergic Receptors' Activation and PI3K Type δ.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 08 2021
Historique:
received: 31 08 2020
accepted: 28 05 2021
pubmed: 1 8 2021
medline: 21 8 2021
entrez: 31 7 2021
Statut: ppublish

Résumé

Mast cells express multiple metabotropic purinergic P2Y receptor (P2YR) subtypes. Few studies have evaluated their role in human mast cell (HMC) allergic response as quantified by degranulation induced by cross-linking the high-affinity IgE receptor (FcεRI). We have previously shown that extracellular nucleotides modify the FcεRI activation-dependent degranulation in HMCs derived from human lungs, but the mechanism of this action has not been fully delineated. This study was undertaken to determine the mechanism of activation of P2YRs on the degranulation of HMCs and elucidate the specific postreceptor pathways involved. Sensitized LAD2 cells, a human-derived mast cell line, were subjected to a weak allergic stimulation (WAS) using a low concentration of Ag in the absence and presence of P2YR agonists. Only the metabotropic purinergic P2Y11 receptor (P2Y11R) agonist, adenosine 5'-(3-thio)triphosphate (ATPγS), enhanced WAS-induced degranulation resulting in a net 7-fold increase in release (

Identifiants

pubmed: 34330752
pii: jimmunol.2001002
doi: 10.4049/jimmunol.2001002
doi:

Substances chimiques

Receptors, Purinergic P2Y 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1001-1008

Informations de copyright

Copyright © 2021 by The American Association of Immunologists, Inc.

Auteurs

Haruhisa Nishi (H)

Department of Pharmacology, Jikei University School of Medicine, Tokyo, Japan; harrywestjpjp@yahoo.co.jp.

François Niyonsaba (F)

Atopy (Allergy) Research Center, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Faculty of International Liberal Arts, Juntendo University, Tokyo, Japan.

Amir Pelleg (A)

Danmir Therapeutics, LLC, Haverford, PA; and.

Edward S Schulman (ES)

Drexel University College of Medicine, Philadelphia, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH